AVN: a potentially serious complication of HIV infection
Are the number of cases increasing?

AIDS Research Alliance has learned that unusually high numbers of the potentially serious condition avascular necrosis, or AVN, have been seen recently in HIV+ individuals at several Los Angeles-area medical practices.

Throughout the epidemic, AVN has only rarely been seen in HIV-infected individuals. As one index of the rarity of AVN in this population, only 23 cases had been reported in the medical literature before 1996. With such a sporadic incidence, clinicians have not been able to solidly identify the associated cause(s) or risk factor(s) for the HIV+ patient, although hyperlipidemia (high fats and cholesterol in the blood) and steroid use might be involved.

AVN occurs when the blood supply to the bone is diminished. Bone is living tissue, and without proper blood supply, it can become brittle and susceptible to breakage. Thus, with time, AVN sufferers can require hip replacement surgery. One unusual aspect of the AVN cases reported to us is that other joints have been affected, such as ankles and knees.

Patients suffering from AVN will experience joint pain. Joint pain, of course, can have many causes. An MRI scan is required to diagnose AVN, because X-rays will not detect the problem.

The fact that physicians at several practices have been seeing more AVN cases recently might indicate that there is an increasing incidence of this condition in the HIV+ population at large. If the number of new cases of AVN in HIV-infected individuals is in fact increasing, that would raise the possibility that these cases are related to treatment choices available only recently, rather than a direct consequence of HIV infection itself.

At the 6th Conference on Retroviruses and Opportunistic Infections, held in February 1999, a group from Georgetown University Medical Center also reported a high incidence of AVN in their HIV patient population, and suggested a link between some cases of AVN in HIV+ individuals and the use of protease inhibitors. However, this suggestion was based on data from only 5 patients. This link cannot be proven without further study of larger numbers of affected patients.

Patients experiencing unusual joint pain should consult a physician. No one should consider discontinuing their medication without first consulting their doctor.

Given the importance of determining whether there has been a true increase in AVN in the HIV+ population, and identifying the risk factor(s) underlying such an increase, AIDS Research Alliance requests that primary care physicians, treatment advocates, and clinical trial investigators who are aware of HIV+ individuals diagnosed with AVN to contact us at the following e-mail address: avn@aidsresearch.org.

As of press time, ARA is scheduled to sponsor a meeting of Los Angeles area healthcare practitioners to discuss this issue on April 27. We will evaluate whether to express our concerns to the FDA based on the responses that we receive.

(The internet contains good resources for learning about AVN, for both lay people and health care professionals. Performing a search for "AVN" on the site orthopedics.about.com/health/orthopedics will yield links worth exploring).

 

 

 

Copyright © 2000 AIDS Research Alliance of America
All Rights Reserved